Publikationen, an denen er mitarbeitet Francisco Javier Escalada San Martín (12)

2023

  1. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  2. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2022

  1. Association between Circulating Levels of 25-Hydroxyvitamin D3 and Matrix Metalloproteinase-10 (MMP-10) in Patients with Type 2 Diabetes

    Nutrients, Vol. 14, Núm. 17

  2. Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease

    Frontiers in Medicine, Vol. 9

  3. Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Diabetic kidney disease, cardiovascular disease and non-alcoholic fatty liver disease: A new triumvirate?

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  2. Optimization of pseudo-continuous arterial spin labeling for renal perfusion imaging

    Magnetic Resonance in Medicine, Vol. 85, Núm. 3, pp. 1507-1521

2020

  1. MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade

    Scientific Reports, Vol. 10, Núm. 1

2017

  1. Arterial spin labeling MRI is able to detect early hemodynamic changes in diabetic nephropathy

    Journal of Magnetic Resonance Imaging, Vol. 46, Núm. 6, pp. 1810-1817

2016

  1. Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge

    Endocrine Pathology, Vol. 27, Núm. 1, pp. 50-54

  2. La paradoja diabética: densidad mineral ósea y fractura en la diabetes tipo 2

    Endocrinologia y Nutricion

2009

  1. La actividad física determinada mediante acelerometría es menor en los pacientes obesos

    Trauma, Vol. 20, Núm. 2, pp. 83-91